Hemifar SRL
2.2 FTEHemifar reported total assets of 724,505 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 2.2 full-time equivalents.
The score of Hemifar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +188 % Total assets -13 % Headcount (avg FTE) -21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hemifar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 42,403 € | ||||
| Equity | 107,875 € | ||||
| Cash | 74,091 € | ||||
| EBITDA | 110,466 € | ||||
| Total assets | 724,505 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 17 Apr 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Hemifar's financial analysis
- Solvency14.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hemifar
Hemifar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0421.142.524
- VAT number
- BE0421142524
- Peppol
- Registered · 0208:0421142524 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Dec 1980
- Registered office
- 2620 Hemiksem
- Size
- Micro · 2.2 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hemifar (SRL) has been based in Hemiksem since 1980, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 42,403 € and equity of 107,875 €; its revenue is not published. With 2.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 14.9%, below the median of its sector (44.2%).
Companies similar to Hemifar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Peutie Retail sale of pharmaceutical products Vilvoorde · balance sheet 724,942 €
- Pharmacie Moens Retail sale of pharmaceutical products Namur · balance sheet 723,808 €
- Brupharma Retail sale of pharmaceutical products Ganshoren · balance sheet 727,515 €
- Farmapunt Achel Retail sale of pharmaceutical products Hamont-Achel · balance sheet 721,434 €
- VAN DEN Abeele - Waerniers Retail sale of pharmaceutical products Maldegem · balance sheet 721,160 €
- MRZK Pharma Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet 721,142 €
- Recipe Retail sale of pharmaceutical products Anderlecht · balance sheet 720,928 €
- Het Apotheekhuis Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 720,768 €
Frequently asked questions about Hemifar
What is the revenue of Hemifar?
Hemifar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hemifar?
In Belgium, the VAT number is the company number prefixed with BE: BE0421142524 for Hemifar, if the company is VAT-registered. Its company number (CBE) is 0421.142.524.
Where is the registered office of Hemifar?
According to the CBE register, the registered office of Hemifar is in 2620 Hemiksem.
What is the equity of Hemifar?
At the close of the 2025 financial year, the equity of Hemifar amounts to 107,875 €, a solvency of 14.9% of total assets.
How many people work at Hemifar?
2.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Hemifar?
The register lists 3 active mandates at Hemifar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hemifar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →